These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21328632)

  • 1. Thiazolidinedione use in elderly patients with type 2 diabetes: with and without heart failure.
    Seong JM; Choi NK; Jung SY; Chang Y; Kim YJ; Lee J; Park BJ
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):344-50. PubMed ID: 21328632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potentially inappropriate prescription of new drug: thiazolidinediones for patients with type II diabetes in Taiwan.
    Wen YW; Tsai YW; Huang WF; Hsiao FY; Chen PF
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):20-9. PubMed ID: 21182151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
    Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R; ;
    Circulation; 2003 Dec; 108(23):2941-8. PubMed ID: 14662691
    [No Abstract]   [Full Text] [Related]  

  • 4. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U; Pop-Busui R; Eagle KA
    Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinediones and congestive heart failure in veterans with type 2 diabetes.
    Toprani A; Fonseca V
    Diabetes Obes Metab; 2011 Mar; 13(3):276-80. PubMed ID: 21205120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?
    Buckingham RE; Hanna A
    Diabetes Obes Metab; 2008 Apr; 10(4):312-28. PubMed ID: 18333890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to the management of diabetic patients with heart failure: role of thiazolidinediones.
    Fonarow GC
    Am Heart J; 2004 Oct; 148(4):551-8. PubMed ID: 15459582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heart failure with thiazolidinedione treatment: what do we know today?].
    Erdmann E
    Dtsch Med Wochenschr; 2009 Jan; 134(4):154-8. PubMed ID: 19148858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
    Masoudi FA; Inzucchi SE; Wang Y; Havranek EP; Foody JM; Krumholz HM
    Circulation; 2005 Feb; 111(5):583-90. PubMed ID: 15699279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protecting the heart while controlling blood sugar. New guidelines help define and refine the use of two diabetes drugs that could be a boon for people who also have heart disease.
    Harv Heart Lett; 2004 Mar; 14(7):1. PubMed ID: 15044139
    [No Abstract]   [Full Text] [Related]  

  • 11. Should antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?
    Gitt AK; Halle M; Hanefeld M; Kellerer M; Marx N; Meier JJ; Schumm-Draeger PM; Bramlage P; Tschöpe D
    Eur J Heart Fail; 2012 Dec; 14(12):1389-400. PubMed ID: 22977264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin therapy in patients with type 2 diabetes complicated by heart failure.
    Inzucchi SE; Masoudi FA; McGuire DK
    Am Heart J; 2007 Dec; 154(6):e45. PubMed ID: 18035066
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
    Rajagopalan R; Rosenson RS; Fernandes AW; Khan M; Murray FT
    Clin Ther; 2004 Sep; 26(9):1400-10. PubMed ID: 15531002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in metformin and insulin utilisation in the Australian veteran population associated with quality use of medicines intervention programs.
    Gadzhanova S; Roughead EE; Loukas K; Vajda J
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):359-65. PubMed ID: 21442685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of heart failure in patients with recent-onset type 2 diabetes: population-based cohort study.
    Leung AA; Eurich DT; Lamb DA; Majumdar SR; Johnson JA; Blackburn DF; McAlister FA
    J Card Fail; 2009 Mar; 15(2):152-7. PubMed ID: 19254675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiazolidinediones and heart failure: a teleo-analysis.
    Singh S; Loke YK; Furberg CD
    Diabetes Care; 2007 Aug; 30(8):2148-53. PubMed ID: 17536074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The increase in the use of drug treatment for diabetes mellitus in the Netherlands, 1998-2003].
    Langendam MW; Hooijkaas C; Piepenbrink JF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1396-401. PubMed ID: 16841589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control study.
    Hartung DM; Touchette DR; Bultemeier NC; Haxby DG
    Pharmacotherapy; 2005 Oct; 25(10):1329-36. PubMed ID: 16185176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolidinediones and congestive heart failure: a judicious balance of risks and benefits.
    Patel RR
    Cardiol Rev; 2009; 17(3):132-5. PubMed ID: 19384087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes, psoriasis and thiazolidinediones.
    Krentz AJ; Friedmann PS
    Int J Clin Pract; 2006 Mar; 60(3):362-3. PubMed ID: 16494655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.